Drug Database
Back to search

France· FR:62654238

XERAVA 100 mg, poudre pour solution à diluer pour perfusion

A eravacycline product containing éravacycline, registered in France by PAION PHARMA (ALLEMAGNE). The same ATC class is registered in 11 of our 19 countries.

ATC J01AA13

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedXERAVA 100 mg, poudre pour solution à…ATCJ01AA13REGISTER NO.FR:62654238PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about éravacyclineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Eravacycline is registered in 11 of 19 countries.

Countries holding a registration under ATC J01AA13 (eravacycline), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose
Search eravacycline products by name

Eravacycline · ATC J01AA13

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ÉRAVACYCLINE
Manufacturer
PAION PHARMA (ALLEMAGNE)
Country
France (FR)
ATC code
J01AA13
ATC class
Eravacycline
Defined daily dose
0.14 g, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955095736
    10 flacons en verre de 10 mL

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

31 interactions on record for eravacycline.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check eravacycline against other medicinesHow interaction checks work

Eravacycline · interactions on record

31 records

  • 11 severe
  • 11 moderate
  • 9 minor

Most severe, free to view

  • AcitretinD05BB02severe
  • IsotretinoinD10AD04severe
  • IsotretinoinD10BA01severe
  • Aminolevulinic acidL01XD04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eravacycline in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eravacycline products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Xerava
  • Liechtenstein · Xerava
  • Norway · Xerava

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/71dc9506-c329-433e-a012-e00c4a3cd730
GET /v1/drugs/71dc9506-c329-433e-a012-e00c4a3cd730?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62654238",
  "date_amm": "2021-02-11",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/18/1312",
  "substance": "ÉRAVACYCLINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about eravacycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console